show episodes
 
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
  continue reading
 
Artwork

1
CCO Oncology Podcast

Clinical Care Options

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
  continue reading
 
Lan-Lan Smith, Editor-in-Chief, and Emma Cookson, Senior Editor at The Lancet Haematology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from racial and ethnic disparities in leukaemia survival outcomes to resuscitation with blood products compared with saline, the link between mental health and lymphoma to haemol ...
  continue reading
 
Artwork

1
All Talk Oncology Cancer Podcast

Kenny Perkins - Your Cancer Guy

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
All Talk Oncology is a Cancer Podcast that empowers cancer patients through insightful conversations that reinforces confidence and certainty about their cancer condition. Transforming a terrifying experience into a manageable one, by arming patients with the understanding they need, and the ability to take control of their treatments through knowledge, allowing effective interaction with their medical team.
  continue reading
 
Artwork

1
Empowered!

Patient Empowerment Network

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome.Our programs enhance patient health literacy to enable shared decision-making and provide informational and educational resources to empo ...
  continue reading
 
Artwork

1
OT Broadcast News

Oncology Times

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
  continue reading
 
Artwork
 
In Start Somewhere, Sara Vaughan talks to some of the inspiring people that she's lucky enough to meet in the course of her work, each with their own unique story of how they started somewhere. Follow Sara Vaughan on Twitter @SaraVaughan and Instagram @saravaughanofficial. Contact: [email protected] Produced by Front Ear Podcasts https://www.frontearpodcasts.com Edited by Nathan Copelin Music by David Cantello Hosted on Acast. See acast.com/privacy for more information.
  continue reading
 
Loading …
show series
 
In this week's episode we’ll find out about longer term results from a pivotal trial of mosunetuzumab in relapsed/refractory follicular lymphoma, potential use of CD70 CAR T-cells that secrete an anti-CD33/anti-CD3 bispecific antibody as a therapy for acute myeloid leukemia, and how ferroptosis regulates hemolysis in stored red blood cells. Feature…
  continue reading
 
- Overview of Clinical Trials & Why They are Important- Understanding Your Treatment Options, Including Clinical Trials- Concerns About Participating in Clinical Trials- Types of Clinical Trials- What Happens in a Clinical Trial?- The Meaning of Informed Consent- Benefits & Risks of Participation- How & Where Clinical Trials are Conducted- How to P…
  continue reading
 
Do you know how the experts use immunotherapy to treat their patients with advanced hepatocellular carcinoma (HCC)? Credit available for this activity expires: 2/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002179?ecd=bdc_podcast_libsyn_mscpedu
  continue reading
 
In this Review Series episode on Basic/Translational Science of Factor VIII, Factor IX, and von Willebrand Factor introduced by Dr. Thomas Ortel, we’ll hear from contributing authors Drs. Ben Samuelson Jones, Mac Monroe and Peter Lenting as they discuss how the functional roles of these 3 proteins are interconnected. Click here to view the complete…
  continue reading
 
In this episode, Shaji K. Kumar, MD, reviews key data on bispecific antibodies used to treat patients with relapsed/refractory multiple myeloma recently presented at the 2024 annual American Society of Hematology meeting, including: Early results with teclistamab combined with anti-CD38 therapy Real-world data with teclistamab including its use aft…
  continue reading
 
In this week's episode we'll learn about asciminib plus dasatinib in Philadelphia chromosome-positive acute leukemia. In a phase 1 study, combining two tyrosine kinase inhibitors with distinct mechanisms of action had encouraging activity in patients with de novo disease. After that: new research demonstrates that the iron exporter ferroportin cont…
  continue reading
 
Did you know recent data reveal that around half of patients with early breast cancer and detectable circulating tumor DNA showed metastases on staging scans? Credit available for this activity expires: 1/15/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002143?ecd=bdc_podcast_libsyn_mscpedu…
  continue reading
 
In this week's episode we’ll learn more about a phase 2 trial of first-line zanubrutinib, obinutuzumab, and venetoclax in TP53-mutated mantle cell lymphoma; early development of hyperdiploidy in multiple myeloma; and a phase 1 trial of the asparaginase pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia. Featured Articles…
  continue reading
 
Did you know that estrogen receptor-targeting therapies could help reduce chemotherapy exposure and its associated toxicities in advanced HER2-positive disease? Credit available for this activity expires: 1/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002178?ecd=bdc_podcast_libsyn_mscpedu…
  continue reading
 
Dr Dawn Swan joins us to discuss current knowledge and future perspectives on the possible association between air pollution and venous thromboembolism. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00291-6/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhae Continue this conversation on social! Follow u…
  continue reading
 
In this week's episode we'll learn about C3-targeted therapy in autoimmune hemolytic anemias. Based on results of an open-label, phase 2 study, pegcetacoplan was well-tolerated, with encouraging efficacy, particularly in patients with cold agglutinin disease. After that: Venetoclax sensitivity testing to predict AML response. In a significant step …
  continue reading
 
Do you know how precision medicine is shaping the future of cancer care? Credit available for this activity expires: 01/13/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-precision-cancer-medicine-unveiling-future-2025a10000dr?ecd=bdc_podcast_libsyn_mscpedu…
  continue reading
 
- Skin Toxicity - How Cancer Treatments Affect Your Skin- The Multidisciplinary Approach to Managing Skin Changes & Irritation- Practical Tips to Manage Rash, Dry/Itchy/Peeling Skin & Nail Changes- Sun Safety Tips During Cancer Treatments- When to Call Your Health Care Team about Skin Toxicity- The Role of Clinical Trials: How Research Increases Yo…
  continue reading
 
Dr Leslie Skeith joins us to discuss the PARTUM pilot trial, comparing low-dose aspirin versus placebo in postpartum venous thromboembolism. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00338-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on social! Follow us today at..…
  continue reading
 
In this week's episode we’ll learn more about an experimental regimen for classical Hodgkin lymphoma that combines brentuximab vedotin, nivolumab, and chemotherapy; a possible role for type 1 interferon signaling in developing autoantibodies to red blood cells in sickle cell disease; and how genomic alterations affecting class I human leukocyte ant…
  continue reading
 
In this week's episode we'll learn about the role of iron in myelodysplastic syndromes, or MDS. After that: long-term treatment outcomes in immune thrombocytopenia from the STOPAGO study. Finally, new insights into APL treatment outcomes and prognostic factors from the large-scale Harmony APL project which used ATRA-Arsenic combination therapy. Fea…
  continue reading
 
In this episode, listen to Virginia Kaklamani, MD, DSc; Erica L. Mayer, MD, MPH; and Laura M. Spring, MD, share their clinical insights and takeaways from a live symposium, including from key abstracts presented at the 2024 San Antonio Breast Cancer Symposium: Estrogen receptor mutations in patients With HR-positive/HER2-negative advanced breast ca…
  continue reading
 
In this inspiring episode, we welcome Dr. Troso, a renowned oncologist with 25 years of experience at Memorial Sloan Kettering. Dr. Troso shares her insights on empowering cancer patients through education, mindset, and advocacy. From discussing advancements in cancer care to her innovative online educational platform, Dr. Troso provides valuable t…
  continue reading
 
Are you up to date on who is at risk for severe COVID-19 outcomes? Learn from our experts in this quickfire question-and-answer activity. Credit available for this activity expires: 1/3/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002037?ecd=bdc_podcast_libsyn_mscpedu…
  continue reading
 
In this week's episode, we’ll learn about the prevalence and impact of dexamethasone dose reductions during triple or quadruple therapy for newly diagnosed multiple myeloma, a conditional knockout mouse model for testing gene therapy in X-linked sideroblastic anemia, and real-world efficacy and safety of ciltacabtagene autoleucel in patients with r…
  continue reading
 
In this week's episode, we'll be comparing BTK inhibitors in relapsed/refractory CLL. Then, we'll hear how researchers in the UK unraveled the genetic background of the AnWj blood group. Finally we'll learn about the role of BCL-2 and BAFF in CLL cell survival following venetoclax therapy. Featured Articles: Deletions in the MAL gene result in loss…
  continue reading
 
Discover key updates on emerging immunotherapy combinations in relapsed/refractory (R/R) follicular lymphoma (FL) from the hematology congress in San Diego. Credit available for this activity expires: 12/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002061?ecd=bdc_podcast_libsyn_mscpedu…
  continue reading
 
- Overview of Blood Cancers- New Research Presented at ASH- Disease-Specific Treatment Updates from ASH on: Leukemia, Lymphoma, Multiple Myeloma & Myeloproliferative Neoplasms (MPNs)- The Role of Precision Medicine & Clinical Trials- Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & D…
  continue reading
 
In this week's episode, we’ll learn more about mechanisms of primary resistance to BCMA-targeted bispecific T-cell engagers in relapsed/refractory multiple myeloma, the effects of emapalumab therapy on outcomes in patients with pediatric hemophagocytic lymphohistiocytosis who receive stem cell transplants, and a cell death process that may help acc…
  continue reading
 
- Overview of the Challenges Young Adults Living with Cancer Face- Talking with the Health Care Team About Survivorship Questions & Concerns- Choosing Who & What to Tell Others: Disclosure- School: Deciding How to Deal with Financing Education– Community College, Technical Training, College, Graduate School – Scholarships- Financial Concerns, Inclu…
  continue reading
 
In this week's episode, unravelling follicular lymphoma subtypes. Researchers dissect the biological diversity of follicular lymphoma and introduce a new prognostic mode, that could change the way this B-cell neoplasm is subtyped and treated. Then, concerning stroke rate trends in sickle cell disease. A new report shows increasing rates of cerebrov…
  continue reading
 
How does a legacy of family cancer shape one's approach to life, business, and personal growth? In this powerful episode, Bella Magazine Editor-in-Chief Vanessa Coppes shares her journey of losing her father to cancer and how it transformed her perspective on leadership and human connection. Through raw and honest conversation, she reveals how her …
  continue reading
 
- Overview of Young Adults Living with Cancer, Including Delays in Diagnosis- Where to Seek Cancer Treatment: Selecting Your Oncology Health Care Team, Including Young Adult Cancer Programs- The Importance of Treatment Summaries- Follow Up with Your Oncologist & Primary Care Doctor- Managing Post Treatment Side Effects/Late Effects- Talking with th…
  continue reading
 
Did you know that despite antiretroviral therapy (ART) and viral suppression, people living with HIV experience chronic inflammation and are at increased risk for comorbidities? Credit available for this activity expires: 12/5/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001967?ecd=bdc_podcast_libsyn_msc…
  continue reading
 
In this week's episode we’ll learn more about how clonal hematopoiesis affects prognosis in patients with telomere biology disorders, consider recently uncovered molecular subtypes of extracutaneous juvenile xanthogranulomas, and discuss a clinical trial of the BCMA-CD3 bispecific antibody teclistamab in patients with relapsed/refractory multiple m…
  continue reading
 
Dr Neema Mayor and Dr Caitlin Farrow from the Anthony Nolan Research Institute join us to discuss the findings of their study on the impact of patient ethnicity on haematopoietic cell transplantation outcomes in the United Kingdom. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00312-0/fulltext?dgcid=buzzs…
  continue reading
 
In this week's podcast, we'll learn about targeting mutant calreticulin in MPNs, or myeloproliferative neoplasms. Then, it’s time to address bleeding and clotting in cancer. Results of the prospective, observational CAT-BLED study provide much needed data on the high risk of clinically relevant bleeding, and its association with all-cause mortality…
  continue reading
 
Are you up to date on the clinical implications of the latest data presented at ESMO 2024? Listen to our expert panel discuss. Credit available for this activity expires: 11/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001849?ecd=bdc_podcast_libsyn_mscpedu…
  continue reading
 
Join us to hear about the latest advancements in immunotherapy for advanced, intermediate-, and early-stage hepatocellular carcinoma (HCC). Credit available for this activity expires: 11/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001794?ecd=bdc_podcast_libsyn_mscpedu…
  continue reading
 
- Why Chemotherapy Causes Treatment Side Effects & Discomfort- Working with Your Healthcare Team to Better Understand & Cope with Potential Treatment Side Effects with a Plan to Manage or Prevent Them- Common Treatment Gastrointestinal (GI) Side Effects - You May Not Experience All of These - Loss of Appetite, Nausea, Vomiting, Mouth Sores, Stomati…
  continue reading
 
In this Review Series episode on T-Cell Lymphomas introduced by Dr. Philippe Armand we’ll hear from Drs. Laurence de Leval, Javeed Iqbal, and Enrica Marchi about their work concerning new treatment practices and insights to various t-cell lymphomas. Click here to view the complete Review Series featured in Volume 144 Issue 18 of Blood.…
  continue reading
 
In this week's episode we’ll learn more about a new risk classification scheme for use in patients with acute myeloid leukemia who are ineligible for intensive therapy, efficacy and safety of daratumumab plus chemotherapy in pediatric patients with acute lymphoblastic leukemia or lymphoblastic lymphoma, and a blood bank-compatible method for creati…
  continue reading
 
Explore strategies for optimizing transplant outcomes through tailoring of tacrolimus therapy. Credit available for this activity expires: 11/18/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001813?ecd=bdc_podcast_libsyn_mscpedu
  continue reading
 
What can an Olympic gold medalist teach us about facing cancer with resilience and grace? In this powerful episode, Shannon Miller, one of America's most decorated gymnasts, shares her journey from Olympic glory to battling a rare form of ovarian cancer. Her story reveals how the discipline and determination that earned her Olympic medals helped he…
  continue reading
 
In this week's episode we'll learn about new explorations in extramedullary myeloma. Then, we'll hear about the role of ruxolitinib in children with acute GvHD. Finally: yapping about YAP1 as a new treatment target in immune thrombocytopenia. Featured Articles: Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction …
  continue reading
 
How does inflammation in people living with HIV contribute to clustered comorbidities, and what strategies can be used to effectively manage them? Credit available for this activity expires: 11/7/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001855?ecd=bdc_podcast_libsyn_mscpedu…
  continue reading
 
In this week's episode we’ll learn more about the ASCEND study, which investigated first-line asciminib in chronic phase chronic myeloid leukemia; a new risk score for myeloid neoplasm transformation in patients with clonal cytopenia of undetermined significance; and use of RHD genotyped D-positive blood transfusions in patients with sickle cell an…
  continue reading
 
In this week's episode we'll learn about the updated phase 3 results on fixed-dose venetoclax plus obinutuzumab in previously untreated CLL. Then, we'll hear about dual epi-immunotherapy in classical Hodgkin lymphoma. Finally we'll explore redefining risk of treatment failure in CML. Featured Articles: Venetoclax-obinutuzumab for previously untreat…
  continue reading
 
In this episode, I've curated a special playlist of podcast episodes for Breast Cancer Awareness Month. I believe that sharing stories and experiences can provide emotional support and inspiration for individuals battling breast cancer. We'll discuss the significance of certain stories, and how listening to others' experiences can help people cope …
  continue reading
 
Loading …

Quick Reference Guide

Listen to this show while you explore
Play